The engineering of specific virus-targeting receptors onto a patient’s own immune cells is now being explored by scientists as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.
The engineering of specific virus-targeting receptors onto a patient’s own immune cells is now being explored by scientists as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.